Showing results (871-880 of 1,326) with videos related to

Sort By:
Pageof 133
Hepatology (Baltimore, Md.)|March 1, 1986
Biological significance of enhanced mitochondrial membrane potential in regenerating liverT Nishihira, J Tanaka, K Nishikawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1985
[Phase II study of UFT for head and neck cancer]Y Inuyama, C Takeda, H Miyake, et al.
Rinsho Hoshasen. Clinical Radiography|February 1, 1990
[Incidence and clinical significance of the esophageal branches originating from the bronchial artery]K Suzuki, J Tanaka, N Kamata, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1989
[Multidisciplinary treatment of head and neck cancer]Y Inuyama, N Kohno, M Fujii, et al.
Cold Spring Harbor Molecular Case Studies|November 18, 2018
A newly identified mutation in the <i>PEX26</i> gene is associated with a milder form of Zellweger spectrum disorderAkemi J Tanaka, Kanji Okumoto, Shigehiko Tamura, et al.
ASAIO Transactions|July 1, 1990
Effects of prostaglandin I2, superoxide dismutase, and catalase on ischemia-reperfusion injury in liver transplantationJ Tanaka, P S Malchesky, S Omokawa, et al.
Alimentary Pharmacology & Therapeutics|April 23, 2002
Successful eradication of Helicobacter pylori prevents relapse of peptic ulcer diseaseT Tomita, Y Fukuda, K Tamura, et al.
British Journal of Haematology|February 1, 1994
Evaluation of mixed chimaerism and origin of bone marrow derived fibroblastoid cells after allogeneic bone marrow transplantationJ Tanaka, M Kasai, M Imamura, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|November 10, 2001
Protective effect of a prosaposin-derived, 18-mer peptide on slowly progressive neuronal degeneration after brief ischemiaF Morita, T C Wen, J Tanaka, et al.
Transplantation|July 27, 1994
In vivo effects of the immunosuppressant 15-deoxyspergualin on hematopoiesis in murine allogeneic bone marrow chimeras. Its thrombopoietic activity and reversal of adverse effects with granulocyte colony-stimulating factor and/or erythropoietinM Imamura, M Han, S Hashino, et al.
Pageof 133